What Chevron’s overturn means for biopharma
Fierce Pharma August 23, 2024
For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of agencies. This stipulation, called the Chevron deference, gave agencies room to advance their regulatory priorities.
The Supreme Court overturned the doctrine...